HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.

Ivonne Haffner, Katrin Schierle, Elba Raimúndez, Birgitta Geier, Dieter Maier, Jan Hasenauer, Birgit Luber, Axel Walch, Katharina Kolbe, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Beate Rau, Ludwig Fischer von Weikersthal, Miriam Ahlborn, Gabriele Siegler (Co-author), Stefan Fuxius, Thomas Decker, Christian Wittekind, Florian Lordick

Research output: Contribution to journalOriginal Articlepeer-review

65 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1468-1478
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume39
Issue number13
DOIs
Publication statusPublished - 2021

Keywords

  • GASTROESOPHAGEAL CANCER
  • GENE AMPLIFICATION
  • TRASTUZUMAB
  • ADENOCARCINOMA
  • THERAPY
  • HETEROGENEITY
  • SENSITIVITY
  • RESISTANCE
  • PROGNOSIS

Cite this